Antispasmodic drugs such as dicyclomine (Bentyl) and hyoscyamine (Levsin) relieve the stomach cramps brought on by IBS by relaxing the smooth muscle of the gut. They also may cause constipation, so they aren't usually prescribed for people who suffer from IBS-C. Other side effects are dry mouth, drowsiness, and blurred vision.
This report aims to provide a comprehensive presentation of the global market for Anti-spasmodic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-spasmodic Drugs. This report contains market size and forecasts of Anti-spasmodic Drugs in global, including the following market information:
Global Anti-spasmodic Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Anti-spasmodic Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Antimuscarinics Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Anti-spasmodic Drugs include Pfizer, Allergan, Ipsen, Teva Pharmaceuticals, Novartis, Johnson & Johnson, Takeda Pharmaceutical, Sun Pharmaceutical Industries and Merz Pharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Anti-spasmodic Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-spasmodic Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Anti-spasmodic Drugs Market Segment Percentages, by Type, 2022 (%)
Antimuscarinics
Smooth Muscle Relaxants
Global Anti-spasmodic Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Anti-spasmodic Drugs Market Segment Percentages, by Application, 2022 (%)
Offline Channel
Online Channel
Global Anti-spasmodic Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Anti-spasmodic Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-spasmodic Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Anti-spasmodic Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Allergan
Ipsen
Teva Pharmaceuticals
Novartis
Johnson & Johnson
Takeda Pharmaceutical
Sun Pharmaceutical Industries
Merz Pharma
Mylan
Fresenius Kabi
Endo International
Daewoong Pharmaceutical
Acorda Therapeutics
SteriMax
Emcure Pharmaceuticals
Sawai Pharmaceutical
Orient Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti-spasmodic Drugs, market overview.
Chapter 2: Global Anti-spasmodic Drugs market size in revenue.
Chapter 3: Detailed analysis of Anti-spasmodic Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-spasmodic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Anti-spasmodic Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-spasmodic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-spasmodic Drugs Overall Market Size
2.1 Global Anti-spasmodic Drugs Market Size: 2022 VS 2029
2.2 Global Anti-spasmodic Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Anti-spasmodic Drugs Players in Global Market
3.2 Top Global Anti-spasmodic Drugs Companies Ranked by Revenue
3.3 Global Anti-spasmodic Drugs Revenue by Companies
3.4 Top 3 and Top 5 Anti-spasmodic Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Anti-spasmodic Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti-spasmodic Drugs Players in Global Market
3.6.1 List of Global Tier 1 Anti-spasmodic Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Anti-spasmodic Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti-spasmodic Drugs Market Size Markets, 2022 & 2029
4.1.2 Antimuscarinics
4.1.3 Smooth Muscle Relaxants
4.2 By Type - Global Anti-spasmodic Drugs Revenue & Forecasts
4.2.1 By Type - Global Anti-spasmodic Drugs Revenue, 2018-2023
4.2.2 By Type - Global Anti-spasmodic Drugs Revenue, 2024-2029
4.2.3 By Type - Global Anti-spasmodic Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anti-spasmodic Drugs Market Size, 2022 & 2029
5.1.2 Offline Channel
5.1.3 Online Channel
5.2 By Application - Global Anti-spasmodic Drugs Revenue & Forecasts
5.2.1 By Application - Global Anti-spasmodic Drugs Revenue, 2018-2023
5.2.2 By Application - Global Anti-spasmodic Drugs Revenue, 2024-2029
5.2.3 By Application - Global Anti-spasmodic Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Anti-spasmodic Drugs Market Size, 2022 & 2029
6.2 By Region - Global Anti-spasmodic Drugs Revenue & Forecasts
6.2.1 By Region - Global Anti-spasmodic Drugs Revenue, 2018-2023
6.2.2 By Region - Global Anti-spasmodic Drugs Revenue, 2024-2029
6.2.3 By Region - Global Anti-spasmodic Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Anti-spasmodic Drugs Revenue, 2018-2029
6.3.2 US Anti-spasmodic Drugs Market Size, 2018-2029
6.3.3 Canada Anti-spasmodic Drugs Market Size, 2018-2029
6.3.4 Mexico Anti-spasmodic Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Anti-spasmodic Drugs Revenue, 2018-2029
6.4.2 Germany Anti-spasmodic Drugs Market Size, 2018-2029
6.4.3 France Anti-spasmodic Drugs Market Size, 2018-2029
6.4.4 U.K. Anti-spasmodic Drugs Market Size, 2018-2029
6.4.5 Italy Anti-spasmodic Drugs Market Size, 2018-2029
6.4.6 Russia Anti-spasmodic Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Anti-spasmodic Drugs Market Size, 2018-2029
6.4.8 Benelux Anti-spasmodic Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Anti-spasmodic Drugs Revenue, 2018-2029
6.5.2 China Anti-spasmodic Drugs Market Size, 2018-2029
6.5.3 Japan Anti-spasmodic Drugs Market Size, 2018-2029
6.5.4 South Korea Anti-spasmodic Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Anti-spasmodic Drugs Market Size, 2018-2029
6.5.6 India Anti-spasmodic Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Anti-spasmodic Drugs Revenue, 2018-2029
6.6.2 Brazil Anti-spasmodic Drugs Market Size, 2018-2029
6.6.3 Argentina Anti-spasmodic Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Anti-spasmodic Drugs Revenue, 2018-2029
6.7.2 Turkey Anti-spasmodic Drugs Market Size, 2018-2029
6.7.3 Israel Anti-spasmodic Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Anti-spasmodic Drugs Market Size, 2018-2029
6.7.5 UAE Anti-spasmodic Drugs Market Size, 2018-2029
7 Anti-spasmodic Drugs Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Anti-spasmodic Drugs Major Product Offerings
7.1.4 Pfizer Anti-spasmodic Drugs Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Allergan
7.2.1 Allergan Company Summary
7.2.2 Allergan Business Overview
7.2.3 Allergan Anti-spasmodic Drugs Major Product Offerings
7.2.4 Allergan Anti-spasmodic Drugs Revenue in Global Market (2018-2023)
7.2.5 Allergan Key News & Latest Developments
7.3 Ipsen
7.3.1 Ipsen Company Summary
7.3.2 Ipsen Business Overview
7.3.3 Ipsen Anti-spasmodic Drugs Major Product Offerings
7.3.4 Ipsen Anti-spasmodic Drugs Revenue in Global Market (2018-2023)
7.3.5 Ipsen Key News & Latest Developments
7.4 Teva Pharmaceuticals
7.4.1 Teva Pharmaceuticals Company Summary
7.4.2 Teva Pharmaceuticals Business Overview
7.4.3 Teva Pharmaceuticals Anti-spasmodic Drugs Major Product Offerings
7.4.4 Teva Pharmaceuticals Anti-spasmodic Drugs Revenue in Global Market (2018-2023)
7.4.5 Teva Pharmaceuticals Key News & Latest Developments
7.5 Novartis
7.5.1 Novartis Company Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Anti-spasmodic Drugs Major Product Offerings
7.5.4 Novartis Anti-spasmodic Drugs Revenue in Global Market (2018-2023)
7.5.5 Novartis Key News & Latest Developments
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Company Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Anti-spasmodic Drugs Major Product Offerings
7.6.4 Johnson & Johnson Anti-spasmodic Drugs Revenue in Global Market (2018-2023)
7.6.5 Johnson & Johnson Key News & Latest Developments
7.7 Takeda Pharmaceutical
7.7.1 Takeda Pharmaceutical Company Summary
7.7.2 Takeda Pharmaceutical Business Overview
7.7.3 Takeda Pharmaceutical Anti-spasmodic Drugs Major Product Offerings
7.7.4 Takeda Pharmaceutical Anti-spasmodic Drugs Revenue in Global Market (2018-2023)
7.7.5 Takeda Pharmaceutical Key News & Latest Developments
7.8 Sun Pharmaceutical Industries
7.8.1 Sun Pharmaceutical Industries Company Summary
7.8.2 Sun Pharmaceutical Industries Business Overview
7.8.3 Sun Pharmaceutical Industries Anti-spasmodic Drugs Major Product Offerings
7.8.4 Sun Pharmaceutical Industries Anti-spasmodic Drugs Revenue in Global Market (2018-2023)
7.8.5 Sun Pharmaceutical Industries Key News & Latest Developments
7.9 Merz Pharma
7.9.1 Merz Pharma Company Summary
7.9.2 Merz Pharma Business Overview
7.9.3 Merz Pharma Anti-spasmodic Drugs Major Product Offerings
7.9.4 Merz Pharma Anti-spasmodic Drugs Revenue in Global Market (2018-2023)
7.9.5 Merz Pharma Key News & Latest Developments
7.10 Mylan
7.10.1 Mylan Company Summary
7.10.2 Mylan Business Overview
7.10.3 Mylan Anti-spasmodic Drugs Major Product Offerings
7.10.4 Mylan Anti-spasmodic Drugs Revenue in Global Market (2018-2023)
7.10.5 Mylan Key News & Latest Developments
7.11 Fresenius Kabi
7.11.1 Fresenius Kabi Company Summary
7.11.2 Fresenius Kabi Business Overview
7.11.3 Fresenius Kabi Anti-spasmodic Drugs Major Product Offerings
7.11.4 Fresenius Kabi Anti-spasmodic Drugs Revenue in Global Market (2018-2023)
7.11.5 Fresenius Kabi Key News & Latest Developments
7.12 Endo International
7.12.1 Endo International Company Summary
7.12.2 Endo International Business Overview
7.12.3 Endo International Anti-spasmodic Drugs Major Product Offerings
7.12.4 Endo International Anti-spasmodic Drugs Revenue in Global Market (2018-2023)
7.12.5 Endo International Key News & Latest Developments
7.13 Daewoong Pharmaceutical
7.13.1 Daewoong Pharmaceutical Company Summary
7.13.2 Daewoong Pharmaceutical Business Overview
7.13.3 Daewoong Pharmaceutical Anti-spasmodic Drugs Major Product Offerings
7.13.4 Daewoong Pharmaceutical Anti-spasmodic Drugs Revenue in Global Market (2018-2023)
7.13.5 Daewoong Pharmaceutical Key News & Latest Developments
7.14 Acorda Therapeutics
7.14.1 Acorda Therapeutics Company Summary
7.14.2 Acorda Therapeutics Business Overview
7.14.3 Acorda Therapeutics Anti-spasmodic Drugs Major Product Offerings
7.14.4 Acorda Therapeutics Anti-spasmodic Drugs Revenue in Global Market (2018-2023)
7.14.5 Acorda Therapeutics Key News & Latest Developments
7.15 SteriMax
7.15.1 SteriMax Company Summary
7.15.2 SteriMax Business Overview
7.15.3 SteriMax Anti-spasmodic Drugs Major Product Offerings
7.15.4 SteriMax Anti-spasmodic Drugs Revenue in Global Market (2018-2023)
7.15.5 SteriMax Key News & Latest Developments
7.16 Emcure Pharmaceuticals
7.16.1 Emcure Pharmaceuticals Company Summary
7.16.2 Emcure Pharmaceuticals Business Overview
7.16.3 Emcure Pharmaceuticals Anti-spasmodic Drugs Major Product Offerings
7.16.4 Emcure Pharmaceuticals Anti-spasmodic Drugs Revenue in Global Market (2018-2023)
7.16.5 Emcure Pharmaceuticals Key News & Latest Developments
7.17 Sawai Pharmaceutical
7.17.1 Sawai Pharmaceutical Company Summary
7.17.2 Sawai Pharmaceutical Business Overview
7.17.3 Sawai Pharmaceutical Anti-spasmodic Drugs Major Product Offerings
7.17.4 Sawai Pharmaceutical Anti-spasmodic Drugs Revenue in Global Market (2018-2023)
7.17.5 Sawai Pharmaceutical Key News & Latest Developments
7.18 Orient Pharma
7.18.1 Orient Pharma Company Summary
7.18.2 Orient Pharma Business Overview
7.18.3 Orient Pharma Anti-spasmodic Drugs Major Product Offerings
7.18.4 Orient Pharma Anti-spasmodic Drugs Revenue in Global Market (2018-2023)
7.18.5 Orient Pharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Anti-spasmodic Drugs Market Opportunities & Trends in Global Market
Table 2. Anti-spasmodic Drugs Market Drivers in Global Market
Table 3. Anti-spasmodic Drugs Market Restraints in Global Market
Table 4. Key Players of Anti-spasmodic Drugs in Global Market
Table 5. Top Anti-spasmodic Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Anti-spasmodic Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Anti-spasmodic Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Anti-spasmodic Drugs Product Type
Table 9. List of Global Tier 1 Anti-spasmodic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-spasmodic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Anti-spasmodic Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Anti-spasmodic Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Anti-spasmodic Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Anti-spasmodic Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Anti-spasmodic Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Anti-spasmodic Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Anti-spasmodic Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Anti-spasmodic Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Anti-spasmodic Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Anti-spasmodic Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Anti-spasmodic Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Anti-spasmodic Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Anti-spasmodic Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Anti-spasmodic Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Anti-spasmodic Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Anti-spasmodic Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Anti-spasmodic Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Anti-spasmodic Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Anti-spasmodic Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Pfizer Company Summary
Table 31. Pfizer Anti-spasmodic Drugs Product Offerings
Table 32. Pfizer Anti-spasmodic Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. Allergan Company Summary
Table 35. Allergan Anti-spasmodic Drugs Product Offerings
Table 36. Allergan Anti-spasmodic Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Allergan Key News & Latest Developments
Table 38. Ipsen Company Summary
Table 39. Ipsen Anti-spasmodic Drugs Product Offerings
Table 40. Ipsen Anti-spasmodic Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Ipsen Key News & Latest Developments
Table 42. Teva Pharmaceuticals Company Summary
Table 43. Teva Pharmaceuticals Anti-spasmodic Drugs Product Offerings
Table 44. Teva Pharmaceuticals Anti-spasmodic Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Teva Pharmaceuticals Key News & Latest Developments
Table 46. Novartis Company Summary
Table 47. Novartis Anti-spasmodic Drugs Product Offerings
Table 48. Novartis Anti-spasmodic Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Novartis Key News & Latest Developments
Table 50. Johnson & Johnson Company Summary
Table 51. Johnson & Johnson Anti-spasmodic Drugs Product Offerings
Table 52. Johnson & Johnson Anti-spasmodic Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Johnson & Johnson Key News & Latest Developments
Table 54. Takeda Pharmaceutical Company Summary
Table 55. Takeda Pharmaceutical Anti-spasmodic Drugs Product Offerings
Table 56. Takeda Pharmaceutical Anti-spasmodic Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Takeda Pharmaceutical Key News & Latest Developments
Table 58. Sun Pharmaceutical Industries Company Summary
Table 59. Sun Pharmaceutical Industries Anti-spasmodic Drugs Product Offerings
Table 60. Sun Pharmaceutical Industries Anti-spasmodic Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Sun Pharmaceutical Industries Key News & Latest Developments
Table 62. Merz Pharma Company Summary
Table 63. Merz Pharma Anti-spasmodic Drugs Product Offerings
Table 64. Merz Pharma Anti-spasmodic Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Merz Pharma Key News & Latest Developments
Table 66. Mylan Company Summary
Table 67. Mylan Anti-spasmodic Drugs Product Offerings
Table 68. Mylan Anti-spasmodic Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Mylan Key News & Latest Developments
Table 70. Fresenius Kabi Company Summary
Table 71. Fresenius Kabi Anti-spasmodic Drugs Product Offerings
Table 72. Fresenius Kabi Anti-spasmodic Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Fresenius Kabi Key News & Latest Developments
Table 74. Endo International Company Summary
Table 75. Endo International Anti-spasmodic Drugs Product Offerings
Table 76. Endo International Anti-spasmodic Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. Endo International Key News & Latest Developments
Table 78. Daewoong Pharmaceutical Company Summary
Table 79. Daewoong Pharmaceutical Anti-spasmodic Drugs Product Offerings
Table 80. Daewoong Pharmaceutical Anti-spasmodic Drugs Revenue (US$, Mn) & (2018-2023)
Table 81. Daewoong Pharmaceutical Key News & Latest Developments
Table 82. Acorda Therapeutics Company Summary
Table 83. Acorda Therapeutics Anti-spasmodic Drugs Product Offerings
Table 84. Acorda Therapeutics Anti-spasmodic Drugs Revenue (US$, Mn) & (2018-2023)
Table 85. Acorda Therapeutics Key News & Latest Developments
Table 86. SteriMax Company Summary
Table 87. SteriMax Anti-spasmodic Drugs Product Offerings
Table 88. SteriMax Anti-spasmodic Drugs Revenue (US$, Mn) & (2018-2023)
Table 89. SteriMax Key News & Latest Developments
Table 90. Emcure Pharmaceuticals Company Summary
Table 91. Emcure Pharmaceuticals Anti-spasmodic Drugs Product Offerings
Table 92. Emcure Pharmaceuticals Anti-spasmodic Drugs Revenue (US$, Mn) & (2018-2023)
Table 93. Emcure Pharmaceuticals Key News & Latest Developments
Table 94. Sawai Pharmaceutical Company Summary
Table 95. Sawai Pharmaceutical Anti-spasmodic Drugs Product Offerings
Table 96. Sawai Pharmaceutical Anti-spasmodic Drugs Revenue (US$, Mn) & (2018-2023)
Table 97. Sawai Pharmaceutical Key News & Latest Developments
Table 98. Orient Pharma Company Summary
Table 99. Orient Pharma Anti-spasmodic Drugs Product Offerings
Table 100. Orient Pharma Anti-spasmodic Drugs Revenue (US$, Mn) & (2018-2023)
Table 101. Orient Pharma Key News & Latest Developments
List of Figures
Figure 1. Anti-spasmodic Drugs Segment by Type in 2022
Figure 2. Anti-spasmodic Drugs Segment by Application in 2022
Figure 3. Global Anti-spasmodic Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anti-spasmodic Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Anti-spasmodic Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anti-spasmodic Drugs Revenue in 2022
Figure 8. By Type - Global Anti-spasmodic Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Anti-spasmodic Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Anti-spasmodic Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Anti-spasmodic Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Anti-spasmodic Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Anti-spasmodic Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Anti-spasmodic Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Anti-spasmodic Drugs Revenue Market Share, 2018-2029
Figure 16. US Anti-spasmodic Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Anti-spasmodic Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Anti-spasmodic Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Anti-spasmodic Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Anti-spasmodic Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Anti-spasmodic Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Anti-spasmodic Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Anti-spasmodic Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Anti-spasmodic Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Anti-spasmodic Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Anti-spasmodic Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Anti-spasmodic Drugs Revenue Market Share, 2018-2029
Figure 28. China Anti-spasmodic Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Anti-spasmodic Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Anti-spasmodic Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Anti-spasmodic Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Anti-spasmodic Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Anti-spasmodic Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Anti-spasmodic Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Anti-spasmodic Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Anti-spasmodic Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Anti-spasmodic Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Anti-spasmodic Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Anti-spasmodic Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Anti-spasmodic Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Pfizer Anti-spasmodic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Allergan Anti-spasmodic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Ipsen Anti-spasmodic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Teva Pharmaceuticals Anti-spasmodic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Novartis Anti-spasmodic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Johnson & Johnson Anti-spasmodic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Takeda Pharmaceutical Anti-spasmodic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Sun Pharmaceutical Industries Anti-spasmodic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Merz Pharma Anti-spasmodic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Mylan Anti-spasmodic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Fresenius Kabi Anti-spasmodic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Endo International Anti-spasmodic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Daewoong Pharmaceutical Anti-spasmodic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Acorda Therapeutics Anti-spasmodic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. SteriMax Anti-spasmodic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Emcure Pharmaceuticals Anti-spasmodic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Sawai Pharmaceutical Anti-spasmodic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Orient Pharma Anti-spasmodic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
